Navigation Links
ESC: Prevention without borders
Date:9/14/2012

Sophia Antipolis, 14 September 2012: Despite Brazil's successful prevention campaigns which have contributed to a reduction in risk factors such as smoking, cardiovascular disease (CVD) remains the first cause of death in the country, at 32%. Tobacco consumption and decrease of salt in local diets are some of the risk factors that will be discussed at the 67th Annual Congress of the Brazilian Society of Cardiology (1) which takes place in Recife, Brazil from 14 to 17 September 2012. This meeting is the largest cardiology conference in Latin America. The Brazilian Society of Cardiology is an affiliated society of the European Society of Cardiology since 2009 and has around 13,000 members.

Brazil's fast development has brought many positive changes to people's lives, but the move from a rural to an urban society has introduced changes in eating and exercise patterns resulting in growing obesity, diabetes and dyslipidaemia in the 185 million population. Cardiovascular mortality in Brazil has increased 3.5 times more than in other developing countries (2) making prevention of CVD an urgent issue. The recently updated European Guidelines on CVD Prevention (3), will be part of the one-day educational session (4) presented in Recife by senior faculty of the ESC together with representatives of the host society. These Guidelines have been reformatted to help disseminate the information from to where it is needed: health professionals working in the field, politicians and the general public.

"Most of CVD related deaths could be prevented through the widespread adoption of simple interventions such as smoking cessation, improved diets and increased exercise. Evidence that CVD is caused by modifiable risk factors, comes from clinical trials and observational community studies," says Professor Panos Vardas, President of the ESC who is leading the European delegation to Brazil. "We will be promoting these and other ESC Guidelines in Brazil. Our agenda (4) also includes highlights from ESC Congress 2012 with the latest information in diagnosing and treating cardiovascular disease as well as "Meet the expert" sessions where ESC faculty will explain recent Clinical Trials that will impact practice."

In recent years, the Brazilian Society of Cardiology has also sought greater international collaboration. Jadelson Pinheiro de Andrade, President of the Brazilian Society of Cardiology said "We think this will be our most international congress ever. We are happy to welcome the ESC sessions once again. Exchanges with our European colleagues are stimulating and we are hoping to collaborate on projects concerning registries and surveys in the future."

The ESC's GSA Committee was established to meet demand for ESC science and knowledge outside of Europe, to build closer ties with international cardiology organisations, and to extend the ESC mission beyond its traditional borders.

"International collaboration is a key objective of the ESC. There are worrying and significant disparities in the way CVD is diagnosed and treated, both in developed and developing countries. We will only be able to fulfill our mission of reducing the burden of CVD by joining forces across frontiers, exchanging experiences and promoting education and research in the cardiovascular field.," concluded Prof Vardas.


'/>"/>
Contact: ESC Press Office
press@escardio.org
33-492-947-756
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. U.S. Expands SIDS Prevention Effort
2. Mayo Clinic suicide prevention expert outlines new steps to tackle military suicide
3. Suicide prevention, telemedicine among topics at Mayo Clinic Transform 2012
4. Wayne State researchers say adolescent smoking prevention programs still critical
5. Stroke Prevention: More Sweet News for Chocolate Lovers
6. High-Risk Heterosexuals Should Take HIV Prevention Pill, Too
7. Landmark HIV treatment-as-prevention study shows additional health benefits, cost-effectiveness
8. Phase III trial of dapivirine ring begins in Africa: New HIV prevention approach for women
9. Prevention of HIV spread focus of NIDAs 2012 Avant-Garde Awards
10. NIH to test maraviroc-based drug regimens for HIV prevention
11. UW study plays pivotal role in todays FDA approval of HIV prevention drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from PsychTests.com reveals that behind ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, ... at his family verbally and physically. , “When something upset him, he couldn’t control his ... it. He would throw rocks at my other children and say he was going to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: